Patients' perspectives on a patient-oriented electronic decision support tool to reduce overuse of proton pump inhibitors (arriba-PPI): a qualitative study in primary care.
Arriba-PPI
General practice
Germany
Primary care
Proton pump inhibitors
Qualitative interviews
Shared decision-making
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
25 01 2023
25 01 2023
Historique:
received:
15
06
2022
accepted:
20
01
2023
entrez:
25
1
2023
pubmed:
26
1
2023
medline:
28
1
2023
Statut:
epublish
Résumé
To evaluate patients' perspectives and their experiences with a consultation involving a computer-assisted and patient-centered discontinuation strategy (arriba-PPI tool) as part of a German multicenter study on reducing the prescription of proton pump inhibitors (PPIs). Qualitative in-depth telephone interviews on proton pump inhibitors with patients who had received an arriba-PPI tool-based counseling by their general practitioner (GP). A random sample of 30 patients was taken from study participants. Interviews were conducted in 2020 and analyzed using a thematic qualitative text analysis. Although this was meant to be the key to shared decision making with regard to PPI reduction, study participants mostly did not recall the visual features of the tool. However, a few patients remembered them very clearly. Above all, patients appreciated a trustful relationship with the GP as well as comprehensive, individualized counseling. Application of the arriba-PPI tool can support the decision process but can also hinder the consultation process if the tool is not properly embedded in the consultation. GPs using the arriba-PPI tool to support the shared decision-making process should consider the patients' and their own expectations on the benefit of the visual representation of the tool.
Sections du résumé
BACKGROUND
To evaluate patients' perspectives and their experiences with a consultation involving a computer-assisted and patient-centered discontinuation strategy (arriba-PPI tool) as part of a German multicenter study on reducing the prescription of proton pump inhibitors (PPIs).
METHODS
Qualitative in-depth telephone interviews on proton pump inhibitors with patients who had received an arriba-PPI tool-based counseling by their general practitioner (GP). A random sample of 30 patients was taken from study participants. Interviews were conducted in 2020 and analyzed using a thematic qualitative text analysis.
RESULTS
Although this was meant to be the key to shared decision making with regard to PPI reduction, study participants mostly did not recall the visual features of the tool. However, a few patients remembered them very clearly. Above all, patients appreciated a trustful relationship with the GP as well as comprehensive, individualized counseling.
CONCLUSION
Application of the arriba-PPI tool can support the decision process but can also hinder the consultation process if the tool is not properly embedded in the consultation. GPs using the arriba-PPI tool to support the shared decision-making process should consider the patients' and their own expectations on the benefit of the visual representation of the tool.
Identifiants
pubmed: 36698061
doi: 10.1186/s12875-023-01991-0
pii: 10.1186/s12875-023-01991-0
pmc: PMC9875449
doi:
Substances chimiques
Proton Pump Inhibitors
0
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Informations de copyright
© 2023. The Author(s).
Références
Digestion. 2005;72(4):212-8
pubmed: 16286734
Cochrane Database Syst Rev. 2014 Dec 02;(12):CD010623
pubmed: 25464111
Trials. 2019 Nov 21;20(1):636
pubmed: 31752978
Cochrane Database Syst Rev. 2004;(3):CD002094
pubmed: 15266462
Eur J Gen Pract. 2014 Sep;20(3):174-80
pubmed: 24219345
Cochrane Database Syst Rev. 2013 May 31;(5):CD002095
pubmed: 23728637
Kidney Int. 2017 Jun;91(6):1482-1494
pubmed: 28237709
Br J Clin Pharmacol. 2015 Oct;80(4):662-9
pubmed: 25980448
JAMA. 2009 May 27;301(20):2120-8
pubmed: 19470989
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Br J Gen Pract. 2001 Sep;51(470):703-11
pubmed: 11593830
Gastroenterology. 1996 Apr;110(4):1244-52
pubmed: 8613015
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
JAMA. 2006 Dec 27;296(24):2947-53
pubmed: 17190895
Aliment Pharmacol Ther. 2011 Sep;34(6):618-27
pubmed: 21770991
Dtsch Arztebl Int. 2016 Jul 11;113(27-28):477-83
pubmed: 27476707
JMIR Med Inform. 2017 Oct 06;5(4):e36
pubmed: 28986341
Patient. 2018 Feb;11(1):17-28
pubmed: 28608038